혈관 스텐트 시스템 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)

The future of the global vascular stent system market looks promising with opportunities in the veins and arteries markets. The global vascular stent system market is expected to grow with a CAGR of 6.9% from 2025 to 2031. The major drivers for this market are the rising prevalence of cardiovascular diseases, advancements in stent technology, and an aging population.

• Lucintel forecasts that, within the type category, 120mm will remain the largest segment over the forecast period because it is designed to treat larger or more complex vascular conditions requiring more extended stent placements.
• Within the application category, arteries will remain the larger segment due to transporting blood under higher pressure from the heart to the body.
• In terms of region, North America is expected to witness the highest growth over the forecast period due to the high adoption of innovative medical technologies.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Vascular Stent System Market

The global vascular stent system market is changing with technological advancements, increased demand for personalized treatments, and regulatory changes that are reshaping the landscape. These emerging trends are focused on improving patient outcomes, enhancing the efficiency of procedures, and expanding market access.

• Bioresorbable Stents: Bioresorbable stents naturally dissolve in the body after serving their purpose and are gaining traction as a leading trend. These stents obviate the need for permanent implants, which reduces complications associated with permanent stent systems. They will be one of the major players in the future of cardiovascular interventions, especially for younger patients requiring temporary vascular support. As the technology matures, bioresorbable stents will capture more market share due to the increasing demand for safer and more effective treatment options.
• Drug-Eluting Stents (DES): Drug-eluting stents (DES) are the critical development in the vascular stent market as they significantly reduce the risk of restenosis, which occurs through direct medication delivery to the artery. DES use is widespread today as they have been shown to improve the outcome for the patient and minimize follow-up procedures. As the market matures, newer DES technologies are being developed to enhance drug delivery further, reduce side effects, and extend the lifespan of the stent. This trend is expected to lead to broader adoption of DES across diverse patient populations.
• Minimally Invasive Techniques and Robotics: Minimally invasive procedures with the support of robotics and high-end imaging are changing the face of the vascular stent market. Robotic-assisted surgery offers better accuracy and precision while reducing recovery times for patients and surgical risks. These technologies make more complex cases treatable in an efficient manner and with fewer complications. As this demand continues to grow, stent systems are expected to see innovation that incorporates compatibility with robotic systems and further visual guidance technologies.
• Customized and Personalized Stent Designs: The growth in understanding vascular diseases results in the rise of custom-designed stent solutions tailored to suit the individual patients' needs. Personalized designs of stents, taking into account factors like artery size, disease progression, and health condition of the patient, are on the rise. With this, more successful results may be seen due to customized stents for distinct anatomical and clinical issues. This trend in personalized medicine is also expected to propel a lot of research into the design of patient-specific stents, which will increase the market scope.
• New Developments in Stent Materials: Material innovation is another significant trend in the vascular stent market; it is still under investigation, studying the design of biocompatible stents that would be less likely to cause complications. New materials, including biodegradable polymers and advanced alloys, are being developed to make stents better in performance and safety. The new materials have the potential to reduce restenosis rates and improve the efficiency of stents in various vascular procedures. It is expected that the use of advanced materials will enhance the long-term success and patient satisfaction of stenting procedures.

New trends, such as bioresorbable stents, drug-eluting stents, minimally invasive techniques, personalized stent designs, and improvements in the material used, are revolutionizing the vascular stent system market around the world. The new products and technologies are expected to benefit patients through improved outcomes and to increase access to stent treatment, ensuring efficient and effective treatments in healthcare delivery systems across the globe.

Recent Developments in the Vascular Stent System Market

The latest developments in the vascular stent system market reflect the trend toward advanced and patient-friendly solutions. Emphasis has been placed on developing safer, more effective, and cost-efficient stents through technological innovation, regulatory advancements, and industry partnerships.

• Advancements in Bioresorbable Stents: One of the most significant advancements in the vascular stent market is bioresorbable stents, which are absorbed by the body over time. These stents provide temporary support to blood vessels, minimize long-term complications, and reduce the need for follow-up procedures. As the technology matures and clinical results continue to show promise, bioresorbable stents are expected to capture a larger share of the market.
• Next-Generation Drug-Eluting Stents: One of the key areas is the development of next-generation drug-eluting stents (DES). These stents deliver medication directly to the affected arteries, thereby preventing restenosis and ensuring better long-term outcomes for patients. Newer DES designs include more effective drugs and polymers that enhance the stent's ability to reduce complications, making them a go-to option for patients with coronary artery disease.
• Robotic-Assisted Stent Placement: Robotic-assisted stent placement has changed the art of delivering precision and safety in stent procedures. Surgeons can now perform the implantation of stents with relative accuracy, hence lower risks for complications and shorter recovery time. As the technology is made more accessible and affordable, this medical practice is likely to take its way into many high-end facilities and many low-resource settings.
• Enhanced Regulatory Approvals: Regulatory bodies like the FDA and EMA have streamlined the approval process for innovative stent systems, allowing for quicker market entry. This regulatory support has encouraged manufacturers to develop new stent technologies that improve clinical outcomes. Faster approvals have accelerated innovation and brought advanced stent systems to patients more efficiently.
• Global Expansion of Stent Manufacturing: The expansion of stent manufacturing capabilities, especially in emerging markets, has made more affordable stent options available worldwide. Manufacturers are establishing production facilities in regions like Asia and Latin America to cater to growing local demand, increasing competition, and making high-quality stent systems more accessible to a wider patient population.

Recent advancements such as bioresorbable stents, drug-eluting stents, robotic-assisted surgery, regulatory improvements, and the expansion of manufacturing into global markets are fueling the growth of the vascular stent system market. These innovations improve the quality of patient care, increase access to treatments, and transform the future of vascular interventions.

Strategic Growth Opportunities in the Vascular Stent System Market

The vascular stent system market provides several strategic growth opportunities across applications, underlined by demand from the advance in materials, technology, and patient care. The worldwide population, which is growing, and the global population continuing to age, is also enhancing demand for products like these.

• Expansion in Emerging Markets: Emerging markets in Asia, Latin America, and Africa present massive growth opportunities for stent manufacturers. Improved healthcare access, rising cardiovascular diseases prevalence, and strong demand for vascular stents ensure an increase in growth in these areas. Large populations with less service access, on whom the companies are venturing to expand, also enhance the expansion of this market.
• Customized Stent Solutions: Advances in personalized medicine open doors for stent manufacturers to design customized stent solutions based on the specific needs of the patient. Advances in imaging technologies and 3D printing enable the production of patient-specific stents, which leads to better results and satisfaction for treatment procedures.
• Consistent with Minimally Invasive Technologies: Manufacturers will have a golden opportunity to innovate with the introduction of stent systems that integrate minimally invasive technologies, including robotic-assisted surgery and advanced imaging techniques. Such technologies provide the exact reproduction of stent placement to decrease complication rates and shorten recovery times for patients' appeal, while the healthcare providers are not left behind to have their space.
• Regenerative Medicine in Stent Design: It can lead the stent market to a more open growth stage by integrating it with vascular stent technology, regenerative medicine. The use of stem cells or bioactive substances within the design may help enhance the healing of vessels further and decrease chances of complications, such as restenosis.
• The drug-eluting and bioresorbable stents: The increasing demand for drug-eluting and bioresorbable stents is an excellent opportunity for manufacturers to focus on developing next-generation stents. These stents offer significant advantages over traditional ones, including improved efficacy, fewer complications, and better long-term patient outcomes.

Expansion opportunities in the vascular stent system market include emerging markets, personalized stent solutions, integration with minimally invasive technologies, regenerative medicine applications, and a focus on drug-eluting and bioresorbable stents. All these will be the factors driving the market forward and furthering patient care around the world.

Vascular Stent System Market Driver and Challenges

The majority of the factors in the vascular stent system market are technology-intensive, economic, and regulatory. Knowing these drivers and challenges is important for market players for the full exploitation of opportunities and the optimization of market pay-offs.

The factors responsible for driving the vascular stent system market include:

1. Technological Advancements: Major factors driving the market are continuous technological advancements in stent materials, design, and delivery mechanisms. Improved patient outcomes due to innovations like bioresorbable stents, drug-eluting stents, and robotic-assisted stent placement increase demand for more advanced solutions.

2. Increasing Prevalence of Cardiovascular Diseases: Rising cases of cardiovascular diseases, more importantly, in the aging population, are providing ample growth for vascular stents. As the incidence of heart disease continues to rise globally, the requirement for effective and reliable stent systems grows, opening a huge growth opportunity in the market.

3. Accessibility and Affordability Healthcare: Improved healthcare infrastructure, especially in emerging markets, is boosting demand for vascular stents. As healthcare becomes more accessible and affordable, more patients are able to undergo stenting procedures, driving market expansion.

4. Regulatory Approvals and Reimbursement Policies: Favorable regulatory policies and improved reimbursement systems are the most important drivers for market growth. Faster approval processes for new stent technologies and favorable reimbursement policies encourage manufacturers to introduce innovative products into the market, facilitating market expansion.

5. Increasing Focus on Minimally Invasive Procedures: The growing preference for minimally invasive procedures is another significant driver of market growth. With advantages such as shorter recovery times and fewer complications, minimally invasive stent placements are gaining popularity, contributing to the overall demand for advanced stent systems.

Challenges in the vascular stent system market are:

1. High Production Costs: The high cost of manufacturing advanced stents, particularly drug-eluting and bioresorbable stents, poses a challenge for market growth. These high production costs can limit the affordability and availability of cutting-edge stent technologies, especially in lower-income regions.

2. Regulatory Hurdles: Despite positive trends, there are challenges associated with the intricate regulatory environment across regions. The regulatory bodies demand high safety, efficacy, and quality standards, which delay the product development process and entry into the market for stent manufacturers.

3. Risk of Restenosis and Complications: Although there have been great improvements in stent technology, restenosis (re-narrowing of arteries) and other complications, such as thrombosis, remain risks associated with stent use. These challenges require ongoing innovation to develop safer, more effective stent systems.

Technological advancement in the vascular stent system is foremost, followed by an increased occurrence of cardiovascular diseases, improved health access, and favorable regulations. The major challenges that face the market are mainly production cost, regulatory hurdles, and the risk of restenosis.

List of Vascular Stent System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, vascular stent system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vascular stent system companies profiled in this report include-

• Boston Scientific
• Koninklijke Philips NV
• Cook Medical
• Bentley Innomed
• Vesper Medical
• Cordis
• Abbott

Vascular Stent System Market by Segment

The study includes a forecast for the global vascular stent system market by type, application, and region.

Vascular Stent System Market by Type [Value from 2019 to 2031]:

• 60Mm
• 80Mm
• 100Mm
• 120Mm
• Others

Vascular Stent System Market by Application [Value from 2019 to 2031]:

• Veins
• Arteries

Vascular Stent System Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Vascular Stent System Market

The global vascular stent system market has grown significantly in the last few years due to technological advancements, increasing prevalence of vascular diseases, and rising awareness about minimally invasive procedures. As medical professionals and companies focus on improving patient outcomes, innovation in stent materials, design, and delivery methods has been pivotal. The United States, China, Germany, India, and Japan are the key markets that are progressing with significant investment in research and development, along with improvements in regulations and increased healthcare infrastructure.

• United States: The vascular stent system market in the United States is growing rapidly due to advanced bioresorbable stents, which can be used temporarily to remove obstructions in blood vessels. There are various new-generation drug-eluting stents (DES) approved by the FDA, which release medication for preventing restenosis, or re-narrowing of arteries. The incidence of cardiovascular diseases is also rising, and healthcare infrastructure is improving along with reimbursement policies. In addition, the use of robotic-assisted surgeries and advanced imaging technologies has made stent placement more precise and minimally invasive.
• China: The vascular stent system market in China is growing rapidly because of the increasing incidence of cardiovascular diseases in the country and improvements in healthcare delivery. Local manufacturers are increasingly producing affordable, high-quality stents to cater to both domestic and international markets. Chinese regulators have streamlined approval processes for medical devices, encouraging innovation and entry into the market. There is a growing need for advanced stent technologies, including bioresorbable and drug-eluting stents, due to the fact that Chinese physicians are now emphasizing patient outcomes by developing individualized treatment plans. Moreover, rapid modernization in China's healthcare system will further expand these technologies.
• Germany: Germany is one of the leaders in medical technology. The country has experienced great improvements in the vascular stent system market. Drug-eluting and bioresorbable stents are among the leading products, with the leading players investing much in R&D to enhance stent performance and minimize complications. The German market benefits from the strict regulatory standards that ensure high-quality stent systems for patients. Widespread provisions under Germany's healthcare system for vascular interventions help make stent technologies more accessible. Integration of advanced imaging and robotic systems into surgery has helped the precision and efficiency of stent placement.
• India: The Indian vascular stent system market is burgeoning with rapid growth attributed to the increasing burden of cardiovascular diseases and widespread awareness of the benefits of stenting procedures. Through government initiatives and foreign investment, India has developed a competitive market for affordable stents catering to both domestic and international needs. Indian manufacturers are adopting global standards, producing high-quality stents, including drug-eluting and bioresorbable, at lower costs. In addition, improvements in the healthcare infrastructure and access to advanced technologies also increase vascular interventions within a larger population in this country.
• Japan: Vascular stent technology is one of the leaders in Japan, with thorough and consistent research and development to make these stent systems even safer and more effective. In this market, there has been massive demand for high-quality drug-eluting stents that prevent the re-narrowing of arteries after stent placement. Bioresorbable stents are another development being invested in Japan and are expected to be a big market driver. Advanced imaging techniques by Japanese healthcare providers are also utilized for finer accuracy of stent placement. The country's elderly population has been contributing to the increasing demand for efficient vascular interventions and stenting solutions.

Features of the Global Vascular Stent System Market

• Market Size Estimates: Vascular stent system market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Vascular stent system market size by type, application, and region in terms of value ($B).
• Regional Analysis: Vascular stent system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the vascular stent system market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the vascular stent system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the vascular stent system market by type (60mm, 80mm, 100mm, 120mm, and others), application (veins and arteries), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Vascular Stent System Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 60 mm: Trends and Forecast (2019-2031)
• 4.4 80 mm: Trends and Forecast (2019-2031)
• 4.5 100 mm: Trends and Forecast (2019-2031)
• 4.6 120 mm: Trends and Forecast (2019-2031)
• 4.7 Others: Trends and Forecast (2019-2031)

5. Global Vascular Stent System Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Veins: Trends and Forecast (2019-2031)
• 5.4 Arteries: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Vascular Stent System Market by Region

7. North American Vascular Stent System Market

• 7.1 Overview
• 7.2 North American Vascular Stent System Market by Type
• 7.3 North American Vascular Stent System Market by Application
• 7.4 United States Vascular Stent System Market
• 7.5 Mexican Vascular Stent System Market
• 7.6 Canadian Vascular Stent System Market

8. European Vascular Stent System Market

• 8.1 Overview
• 8.2 European Vascular Stent System Market by Type
• 8.3 European Vascular Stent System Market by Application
• 8.4 German Vascular Stent System Market
• 8.5 French Vascular Stent System Market
• 8.6 Spanish Vascular Stent System Market
• 8.7 Italian Vascular Stent System Market
• 8.8 United Kingdom Vascular Stent System Market

9. APAC Vascular Stent System Market

• 9.1 Overview
• 9.2 APAC Vascular Stent System Market by Type
• 9.3 APAC Vascular Stent System Market by Application
• 9.4 Japanese Vascular Stent System Market
• 9.5 Indian Vascular Stent System Market
• 9.6 Chinese Vascular Stent System Market
• 9.7 South Korean Vascular Stent System Market
• 9.8 Indonesian Vascular Stent System Market

10. ROW Vascular Stent System Market

• 10.1 Overview
• 10.2 ROW Vascular Stent System Market by Type
• 10.3 ROW Vascular Stent System Market by Application
• 10.4 Middle Eastern Vascular Stent System Market
• 10.5 South American Vascular Stent System Market
• 10.6 African Vascular Stent System Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Vascular Stent System Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Boston Scientific
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Koninklijke Philips NV
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Cook Medical
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Bentley Innomed
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Vesper Medical
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Cordis
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Abbott
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us